1![NOPT-1451 GBM Resource Guide Ad.indd NOPT-1451 GBM Resource Guide Ad.indd](https://www.pdfsearch.io/img/668caea2a8ddd50fe978c12e8766140e.jpg) | Add to Reading ListSource URL: www.onclive.comLanguage: English - Date: 2015-05-07 09:19:41
|
---|
2![NOPT-1451 GBM Resource Guide Ad.indd NOPT-1451 GBM Resource Guide Ad.indd](https://www.pdfsearch.io/img/278d40be5bb2b4cbd009efe46e77daa4.jpg) | Add to Reading ListSource URL: curemagazine.s3.amazonaws.comLanguage: English - Date: 2015-05-07 16:12:34
|
---|
3![Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer Award ID: DP150031 Project Title: A Multi-Targeted Approach for Recurrent Glioblastoma and Other Aggressive Cancers: Exploiting the Potential of IL-4 Fusion Proteins Treatment of Cancer](https://www.pdfsearch.io/img/2e1f781c03195041cbfed534099b4471.jpg) | Add to Reading ListSource URL: www.cprit.state.tx.usLanguage: English - Date: 2015-03-24 12:30:06
|
---|
4![Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success Data presented today as a late](https://www.pdfsearch.io/img/33969b0d6e6e98cafb797e63e3fbd87d.jpg) | Add to Reading ListSource URL: novocure.comLanguage: English - Date: 2014-11-20 09:23:21
|
---|
5![Horizon Scanning Briefing Template Horizon Scanning Briefing Template](https://www.pdfsearch.io/img/8935c92c817d352880caba02a63b8af6.jpg) | Add to Reading ListSource URL: www.horizonscanning.gov.auLanguage: English - Date: 2011-03-28 22:54:07
|
---|
6![Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified Novocure™ Certifies Eight Additional Clinical Centers of Excellence to Treat Most Common Brain Tumor with Tumor Treating Fields (TTFields) Therapy By June 1, a total of 15 clinical centers in the U.S. will be certified](https://www.pdfsearch.io/img/cd83aee45ed200a1b206c844a866c4f7.jpg) | Add to Reading ListSource URL: www.novocure.comLanguage: English - Date: 2014-07-10 11:18:41
|
---|
7![Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent](https://www.pdfsearch.io/img/92bb5ead12c5744cb59803a323f3fbeb.jpg) | Add to Reading ListSource URL: virtualtrials.comLanguage: English - Date: 2013-01-14 14:17:41
|
---|
8![Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t](https://www.pdfsearch.io/img/da80f7a933d346e32479246147aa4b6e.jpg) | Add to Reading ListSource URL: virtualtrials.comLanguage: English - Date: 2011-12-03 17:34:25
|
---|
9![Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t](https://www.pdfsearch.io/img/85f2934ae93c7d5680660e8a75820e5d.jpg) | Add to Reading ListSource URL: www.virtualtrials.comLanguage: English - Date: 2011-12-03 17:34:25
|
---|
10![Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent Med Oncol[removed]:338 DOI[removed]s12032[removed]SHORT COMMUNICATION Delayed response and survival from NovoTTF-100A in recurrent](https://www.pdfsearch.io/img/c98ae16dd6a0e68b2fae337c35d8a290.jpg) | Add to Reading ListSource URL: www.virtualtrials.comLanguage: English - Date: 2013-01-14 14:17:41
|
---|